Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2022 Financial Results
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on February 6, 2023
Corporate Presentation Link Pending
Neurocrine Biosciences Presented at the 41st Annual J.P. Morgan Healthcare Conference
Kevin Gorman, Chief Executive Officer, presented at the 2023 J.P. Morgan Healthcare Conference at 11:15 a.m. Pacific Time on Monday, January 9, 2023 in San Francisco. The presentation was followed by a question and answer session.